Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00403052
Recruitment Status : Terminated (Administrative reasons)
First Posted : November 23, 2006
Last Update Posted : April 16, 2019
Information provided by (Responsible Party):
Dynavax Technologies Corporation

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2007